Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Alnylam Pharmaceuticals Inc Share Price

ALNY

NSQ

$320

-$8.16

(-2.49%)

Industry: Biotechnology Sector: Health Care

Alnylam Pharmaceuticals Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Alnylam Pharmaceuticals Inc Share Price Chart

Alnylam Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$43.35B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

1093.8666

Volume

This is the total number of shares traded during the most recent trading day.

1.39M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.35

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$205.87 L

$495.55 H

$320

About Alnylam Pharmaceuticals Inc, Common Stock

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated amyloidosis; GIVLAARI for acute hepatic porphyria; OXLUMO for primary hyperoxaluria type 1; and Leqvio for hypercholesterolemia. It also develops vutrisiran, which is in phase III clinical trial for transthyretin amyloidosis (ATTR) with cardiomyopathy; Nucresiran that is in phase I clinical trial for ATTR amyloidosis; Fitusiran, which is in phase III clinical trial for hemophilia; cemdisiran that is in phase III clinical trial for Myasthenia Gravis and paroxysmal nocturnal hemoglobinuria, and geographic atrophy; and ALN-6400, which is in phase I clinical trial for bleeding disorders. In addition, the company is also developing Zilebesiran, which is in phase II clinical trial for hypertension; Rapirosiran that is in phase II clinical trial for Metabolic dysfunction-associated steatohepatitis; ALN-4324, which is in phase I clinical trial for type 2 diabetes mellitus; ALN-PNP that is in phase I clinical trial for non-alcoholic fatty liver disease; ALN-APOC3, which is in phase I clinical trial for dyslipidemia; Mivelsiran that is in phase II clinical trial for cerebral amyloid angiopathy, and phase I clinical trial for Alzheimer's disease; and ALN-HTT02 that is in phase I clinical trial for Huntington's disease. Further, it develops ALN-SOD, which is in phase II clinical trial for SOD1 Amyotrophic lateral sclerosis; Elebsiran that is in phase II clinical trial for Hepatitis B and D virus infections; ALN-BCAT that is in phase I clinical trial for hepatocellular carcinoma; and ALN-ANG3. It has collaborations with Regeneron Pharmaceuticals, Inc.; Roche Holding AG; Regeneron Pharmaceuticals, Inc.; Sanofi S.A.; Novartis AG; PeptiDream, Inc; Dicerna Pharmaceuticals, Inc.; and Ionis Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Alnylam Pharmaceuticals Inc Stock Returns

Time Frame	ALNY	Sector	S&P500
1-Week Return	-3.23%	1.3%	-0.69%
1-Month Return	-17.61%	0.25%	-0.48%
3-Month Return	-25.71%	7.08%	1.4%
6-Month Return	-24.56%	21.05%	8.67%
1-Year Return	19.74%	7.8%	14.22%
3-Year Return	52.22%	20.16%	69.8%
5-Year Return	95.74%	35.98%	77.06%
10-Year Return	454.14%	146.46%	273.69%

Time Frame	ALNY	Sector	S&P500
1-Week Return	-81.95%	96.11%	-30.30%
1-Month Return	-90.53%	3.08%	-5.69%
3-Month Return	-70.04%	31.97%	5.80%
6-Month Return	-43.53%	47.31%	18.36%
1-Year Return	19.74%	7.80%	14.22%
3-Year Return	15.03%	6.31%	19.30%
5-Year Return	14.38%	6.34%	12.10%
10-Year Return	18.68%	9.44%	14.09%

Alnylam Pharmaceuticals Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	492.85M	844.29M	1.04B	1.83B	2.25B	[{"date":"2020-12-31","value":21.92,"profit":true},{"date":"2021-12-31","value":37.55,"profit":true},{"date":"2022-12-31","value":46.14,"profit":true},{"date":"2023-12-31","value":81.32,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	78.05M	140.14M	168.82M	310.41M	323.37M	[{"date":"2020-12-31","value":24.14,"profit":true},{"date":"2021-12-31","value":43.34,"profit":true},{"date":"2022-12-31","value":52.21,"profit":true},{"date":"2023-12-31","value":95.99,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	414.80M	704.14M	868.60M	1.52B	1.92B	[{"date":"2020-12-31","value":21.55,"profit":true},{"date":"2021-12-31","value":36.58,"profit":true},{"date":"2022-12-31","value":45.13,"profit":true},{"date":"2023-12-31","value":78.86,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	84.16%	83.40%	83.73%	83.02%	85.62%	[{"date":"2020-12-31","value":98.3,"profit":true},{"date":"2021-12-31","value":97.41,"profit":true},{"date":"2022-12-31","value":97.79,"profit":true},{"date":"2023-12-31","value":96.97,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Operating Expenses	1.24B	1.41B	1.65B	1.80B	2.10B	[{"date":"2020-12-31","value":59.15,"profit":true},{"date":"2021-12-31","value":67.22,"profit":true},{"date":"2022-12-31","value":78.68,"profit":true},{"date":"2023-12-31","value":85.65,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(828.44M)	(708.65M)	(785.07M)	(282.18M)	(176.88M)	[{"date":"2020-12-31","value":-82843800000,"profit":false},{"date":"2021-12-31","value":-70865200000,"profit":false},{"date":"2022-12-31","value":-78507200000,"profit":false},{"date":"2023-12-31","value":-28217500000,"profit":false},{"date":"2024-12-31","value":-17688500000,"profit":false}]
Total Non-Operating Income/Expense	(99.85M)	(284.93M)	(473.08M)	(177.00M)	(220.36M)	[{"date":"2020-12-31","value":-9984900000,"profit":false},{"date":"2021-12-31","value":-28493400000,"profit":false},{"date":"2022-12-31","value":-47308100000,"profit":false},{"date":"2023-12-31","value":-17700200000,"profit":false},{"date":"2024-12-31","value":-22035600000,"profit":false}]
Pre-Tax Income	(855.60M)	(852.14M)	(1.13B)	(433.52M)	(377.38M)	[{"date":"2020-12-31","value":-85560000000,"profit":false},{"date":"2021-12-31","value":-85214400000,"profit":false},{"date":"2022-12-31","value":-112699300000,"profit":false},{"date":"2023-12-31","value":-43351700000,"profit":false},{"date":"2024-12-31","value":-37737500000,"profit":false}]
Income Taxes	2.68M	680.00K	4.16M	6.72M	(99.22M)	[{"date":"2020-12-31","value":39.87,"profit":true},{"date":"2021-12-31","value":10.11,"profit":true},{"date":"2022-12-31","value":61.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1475.36,"profit":false}]
Income After Taxes	(858.28M)	(852.82M)	(1.13B)	(440.24M)	(278.16M)	[{"date":"2020-12-31","value":-85828100000,"profit":false},{"date":"2021-12-31","value":-85282400000,"profit":false},{"date":"2022-12-31","value":-113115600000,"profit":false},{"date":"2023-12-31","value":-44024200000,"profit":false},{"date":"2024-12-31","value":-27815700000,"profit":false}]

Income From Continuous Operations	(858.28M)	(852.82M)	(1.13B)	(440.24M)	(278.16M)	[{"date":"2020-12-31","value":-85828100000,"profit":false},{"date":"2021-12-31","value":-85282400000,"profit":false},{"date":"2022-12-31","value":-113115600000,"profit":false},{"date":"2023-12-31","value":-44024200000,"profit":false},{"date":"2024-12-31","value":-27815700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(858.28M)	(852.82M)	(1.13B)	(440.24M)	(278.16M)	[{"date":"2020-12-31","value":-85828100000,"profit":false},{"date":"2021-12-31","value":-85282400000,"profit":false},{"date":"2022-12-31","value":-113115600000,"profit":false},{"date":"2023-12-31","value":-44024200000,"profit":false},{"date":"2024-12-31","value":-27815700000,"profit":false}]

EPS (Diluted)	(7.66)	(7.12)	(8.66)	(3.56)	(1.09)	[{"date":"2020-12-31","value":-766,"profit":false},{"date":"2021-12-31","value":-712,"profit":false},{"date":"2022-12-31","value":-866,"profit":false},{"date":"2023-12-31","value":-356,"profit":false},{"date":"2024-12-31","value":-109,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	71.31%	22.88%	76.23%	22.97%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":93.53,"profit":true},{"date":"2022-12-31","value":30.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":30.13,"profit":true}]
Cost of Revenue	-	79.55%	20.46%	83.87%	4.18%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":94.85,"profit":true},{"date":"2022-12-31","value":24.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":4.98,"profit":true}]
Gross Profit	-	69.75%	23.36%	74.75%	26.81%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":93.32,"profit":true},{"date":"2022-12-31","value":31.24,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":35.87,"profit":true}]
Gross Margin	-	(0.91%)	0.39%	(0.84%)	3.13%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-28.98,"profit":false},{"date":"2022-12-31","value":12.52,"profit":true},{"date":"2023-12-31","value":-26.95,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Operating Expenses	-	13.64%	17.05%	8.85%	16.76%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":79.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":51.92,"profit":true},{"date":"2024-12-31","value":98.3,"profit":true}]
Operating Income	-	(14.46%)	10.78%	(64.06%)	(37.31%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-134.08,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-594.01,"profit":false},{"date":"2024-12-31","value":-346.01,"profit":false}]
Total Non-Operating Income/Expense	-	185.36%	66.03%	(62.59%)	24.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":35.62,"profit":true},{"date":"2023-12-31","value":-33.76,"profit":false},{"date":"2024-12-31","value":13.21,"profit":true}]
Pre-Tax Income	-	(0.40%)	32.25%	(61.53%)	(12.95%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.25,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-190.78,"profit":false},{"date":"2024-12-31","value":-40.15,"profit":false}]
Income Taxes	-	(74.64%)	512.21%	61.54%	(1575.36%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-14.57,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":12.02,"profit":true},{"date":"2024-12-31","value":-307.56,"profit":false}]
Income After Taxes	-	(0.64%)	32.64%	(61.08%)	(36.82%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.95,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-187.15,"profit":false},{"date":"2024-12-31","value":-112.81,"profit":false}]

Income From Continuous Operations	-	(0.64%)	32.64%	(61.08%)	(36.82%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.95,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-187.15,"profit":false},{"date":"2024-12-31","value":-112.81,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(0.64%)	32.64%	(61.08%)	(36.82%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.95,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-187.15,"profit":false},{"date":"2024-12-31","value":-112.81,"profit":false}]

EPS (Diluted)	-	(7.05%)	21.63%	(58.89%)	(69.38%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-32.59,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-272.28,"profit":false},{"date":"2024-12-31","value":-320.78,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	500.92M	593.17M	594.19M	773.69M	1.25B	[{"date":"2024-09-30","value":40.1,"profit":true},{"date":"2024-12-31","value":47.49,"profit":true},{"date":"2025-03-31","value":47.57,"profit":true},{"date":"2025-06-30","value":61.94,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	85.91M	102.82M	71.04M	142.95M	197.23M	[{"date":"2024-09-30","value":43.56,"profit":true},{"date":"2024-12-31","value":52.13,"profit":true},{"date":"2025-03-31","value":36.02,"profit":true},{"date":"2025-06-30","value":72.48,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	415.01M	490.35M	523.15M	630.74M	1.05B	[{"date":"2024-09-30","value":39.46,"profit":true},{"date":"2024-12-31","value":46.62,"profit":true},{"date":"2025-03-31","value":49.74,"profit":true},{"date":"2025-06-30","value":59.97,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	82.85%	82.67%	88.04%	81.52%	84.21%	[{"date":"2024-09-30","value":94.1,"profit":true},{"date":"2024-12-31","value":93.89,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":92.59,"profit":true},{"date":"2025-09-30","value":95.64,"profit":true}]

Operating Expenses	491.92M	595.51M	505.07M	646.93M	683.81M	[{"date":"2024-09-30","value":71.94,"profit":true},{"date":"2024-12-31","value":87.09,"profit":true},{"date":"2025-03-31","value":73.86,"profit":true},{"date":"2025-06-30","value":94.61,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Operating Income	(76.91M)	(105.16M)	18.08M	(16.20M)	367.98M	[{"date":"2024-09-30","value":-20.9,"profit":false},{"date":"2024-12-31","value":-28.58,"profit":false},{"date":"2025-03-31","value":4.91,"profit":true},{"date":"2025-06-30","value":-4.4,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Non-Operating Income/Expense	(33.99M)	(96.75M)	(69.65M)	(31.92M)	(144.73M)	[{"date":"2024-09-30","value":-3398800000,"profit":false},{"date":"2024-12-31","value":-9675100000,"profit":false},{"date":"2025-03-31","value":-6964600000,"profit":false},{"date":"2025-06-30","value":-3191900000,"profit":false},{"date":"2025-09-30","value":-14473000000,"profit":false}]
Pre-Tax Income	(108.66M)	(193.96M)	(41.60M)	(35.36M)	238.97M	[{"date":"2024-09-30","value":-45.47,"profit":false},{"date":"2024-12-31","value":-81.16,"profit":false},{"date":"2025-03-31","value":-17.41,"profit":false},{"date":"2025-06-30","value":-14.8,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Income Taxes	2.91M	(110.19M)	15.88M	30.92M	(12.12M)	[{"date":"2024-09-30","value":9.4,"profit":true},{"date":"2024-12-31","value":-356.4,"profit":false},{"date":"2025-03-31","value":51.37,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-39.18,"profit":false}]
Income After Taxes	(111.57M)	(83.76M)	(57.48M)	(66.28M)	251.08M	[{"date":"2024-09-30","value":-44.44,"profit":false},{"date":"2024-12-31","value":-33.36,"profit":false},{"date":"2025-03-31","value":-22.89,"profit":false},{"date":"2025-06-30","value":-26.4,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Income From Continuous Operations	(111.57M)	(83.76M)	(57.48M)	(66.28M)	251.08M	[{"date":"2024-09-30","value":-44.44,"profit":false},{"date":"2024-12-31","value":-33.36,"profit":false},{"date":"2025-03-31","value":-22.89,"profit":false},{"date":"2025-06-30","value":-26.4,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(111.57M)	(83.76M)	(57.48M)	(66.28M)	251.08M	[{"date":"2024-09-30","value":-44.44,"profit":false},{"date":"2024-12-31","value":-33.36,"profit":false},{"date":"2025-03-31","value":-22.89,"profit":false},{"date":"2025-06-30","value":-26.4,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

EPS (Diluted)	(0.50)	0.06	(0.01)	(0.51)	2.90	[{"date":"2024-09-30","value":-17.24,"profit":false},{"date":"2024-12-31","value":2.07,"profit":true},{"date":"2025-03-31","value":-0.34,"profit":false},{"date":"2025-06-30","value":-17.59,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	18.42%	0.17%	30.21%	61.44%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":29.97,"profit":true},{"date":"2025-03-31","value":0.28,"profit":true},{"date":"2025-06-30","value":49.17,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	-	19.69%	(30.91%)	101.23%	37.97%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":19.45,"profit":true},{"date":"2025-03-31","value":-30.53,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":37.51,"profit":true}]
Gross Profit	-	18.15%	6.69%	20.57%	66.76%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":27.19,"profit":true},{"date":"2025-03-31","value":10.02,"profit":true},{"date":"2025-06-30","value":30.81,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	-	(0.22%)	6.51%	(7.41%)	3.29%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-3.42,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-113.85,"profit":false},{"date":"2025-09-30","value":50.65,"profit":true}]

Operating Expenses	-	21.06%	(15.19%)	28.09%	5.70%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":74.97,"profit":true},{"date":"2025-03-31","value":-54.07,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":20.29,"profit":true}]
Operating Income	-	36.74%	(117.19%)	(189.61%)	(2371.63%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-318.98,"profit":false},{"date":"2025-06-30","value":-516.11,"profit":false},{"date":"2025-09-30","value":-6455.39,"profit":false}]
Total Non-Operating Income/Expense	-	184.66%	(28.02%)	(54.17%)	353.43%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":52.25,"profit":true},{"date":"2025-03-31","value":-7.93,"profit":false},{"date":"2025-06-30","value":-15.33,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Pre-Tax Income	-	78.49%	(78.55%)	(15.00%)	(775.86%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-100.08,"profit":false},{"date":"2025-06-30","value":-19.11,"profit":false},{"date":"2025-09-30","value":-988.41,"profit":false}]
Income Taxes	-	(3890.68%)	(114.41%)	94.67%	(139.18%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-4109.85,"profit":false},{"date":"2025-03-31","value":-120.86,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-147.02,"profit":false}]
Income After Taxes	-	(24.92%)	(31.38%)	15.31%	(478.84%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-162.83,"profit":false},{"date":"2025-03-31","value":-205.01,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-3128.35,"profit":false}]

Income From Continuous Operations	-	(24.92%)	(31.38%)	15.31%	(478.84%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-162.83,"profit":false},{"date":"2025-03-31","value":-205.01,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-3128.35,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(24.92%)	(31.38%)	15.31%	(478.84%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-162.83,"profit":false},{"date":"2025-03-31","value":-205.01,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-3128.35,"profit":false}]

EPS (Diluted)	-	(112.00%)	(116.67%)	5000.00%	(668.63%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-2.24,"profit":false},{"date":"2025-03-31","value":-2.33,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-13.37,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	2.61B	2.81B	2.69B	2.98B	3.30B	[{"date":"2020-12-31","value":79.35,"profit":true},{"date":"2021-12-31","value":85.23,"profit":true},{"date":"2022-12-31","value":81.7,"profit":true},{"date":"2023-12-31","value":90.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	792.28M	834.73M	854.11M	847.18M	944.70M	[{"date":"2020-12-31","value":83.87,"profit":true},{"date":"2021-12-31","value":88.36,"profit":true},{"date":"2022-12-31","value":90.41,"profit":true},{"date":"2023-12-31","value":89.68,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	3.41B	3.64B	3.55B	3.83B	4.24B	[{"date":"2020-12-31","value":80.36,"profit":true},{"date":"2021-12-31","value":85.93,"profit":true},{"date":"2022-12-31","value":83.64,"profit":true},{"date":"2023-12-31","value":90.33,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	585.27M	695.71M	767.91M	967.79M	1.19B	[{"date":"2020-12-31","value":49.34,"profit":true},{"date":"2021-12-31","value":58.65,"profit":true},{"date":"2022-12-31","value":64.73,"profit":true},{"date":"2023-12-31","value":81.58,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	1.81B	2.36B	2.94B	3.08B	2.99B	[{"date":"2020-12-31","value":58.57,"profit":true},{"date":"2021-12-31","value":76.54,"profit":true},{"date":"2022-12-31","value":95.26,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.88,"profit":true}]
Total Liabilities	2.39B	3.06B	3.70B	4.05B	4.17B	[{"date":"2020-12-31","value":57.29,"profit":true},{"date":"2021-12-31","value":73.21,"profit":true},{"date":"2022-12-31","value":88.78,"profit":true},{"date":"2023-12-31","value":97.07,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	1.16M	1.20M	1.24M	1.26M	1.29M	[{"date":"2020-12-31","value":90.02,"profit":true},{"date":"2021-12-31","value":92.96,"profit":true},{"date":"2022-12-31","value":95.9,"profit":true},{"date":"2023-12-31","value":97.37,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(4.59B)	(5.44B)	(6.57B)	(7.01B)	(7.29B)	[{"date":"2020-12-31","value":-458536900000,"profit":false},{"date":"2021-12-31","value":-543819300000,"profit":false},{"date":"2022-12-31","value":-656934900000,"profit":false},{"date":"2023-12-31","value":-700959100000,"profit":false},{"date":"2024-12-31","value":-728774800000,"profit":false}]
Other Stockholders' Equity	5.64B	6.06B	6.45B	6.81B	7.39B	[{"date":"2020-12-31","value":76.39,"profit":true},{"date":"2021-12-31","value":82,"profit":true},{"date":"2022-12-31","value":87.36,"profit":true},{"date":"2023-12-31","value":92.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	1.02B	588.20M	(158.22M)	(220.64M)	67.09M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":57.88,"profit":true},{"date":"2022-12-31","value":-15.57,"profit":false},{"date":"2023-12-31","value":-21.71,"profit":false},{"date":"2024-12-31","value":6.6,"profit":true}]

Total Liabilities & Shareholders Equity	3.41B	3.64B	3.55B	3.83B	4.24B	[{"date":"2020-12-31","value":80.36,"profit":true},{"date":"2021-12-31","value":85.93,"profit":true},{"date":"2022-12-31","value":83.64,"profit":true},{"date":"2023-12-31","value":90.33,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	7.41%	(4.14%)	10.79%	10.48%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":68.7,"profit":true},{"date":"2022-12-31","value":-38.39,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":97.14,"profit":true}]
Non-current Assets	-	5.36%	2.32%	(0.81%)	11.51%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":46.54,"profit":true},{"date":"2022-12-31","value":20.17,"profit":true},{"date":"2023-12-31","value":-7.05,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	6.93%	(2.66%)	7.99%	10.71%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":64.75,"profit":true},{"date":"2022-12-31","value":-24.85,"profit":false},{"date":"2023-12-31","value":74.66,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	18.87%	10.38%	26.03%	22.58%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":72.5,"profit":true},{"date":"2022-12-31","value":39.88,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":86.74,"profit":true}]
Non-current Liabilities	-	30.67%	24.47%	4.97%	(3.12%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":79.76,"profit":true},{"date":"2023-12-31","value":16.22,"profit":true},{"date":"2024-12-31","value":-10.16,"profit":false}]
Total Liabilities	-	27.78%	21.26%	9.34%	3.02%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":76.51,"profit":true},{"date":"2023-12-31","value":33.61,"profit":true},{"date":"2024-12-31","value":10.87,"profit":true}]

Total Shareholders' equity
Common Stock	-	3.26%	3.16%	1.53%	2.70%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.84,"profit":true},{"date":"2023-12-31","value":46.94,"profit":true},{"date":"2024-12-31","value":82.72,"profit":true}]
Retained Earnings	-	18.60%	20.80%	6.70%	3.97%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":89.42,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":32.22,"profit":true},{"date":"2024-12-31","value":19.08,"profit":true}]
Other Stockholders' Equity	-	7.34%	6.54%	5.52%	8.47%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":86.67,"profit":true},{"date":"2022-12-31","value":77.17,"profit":true},{"date":"2023-12-31","value":65.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	(42.12%)	(126.90%)	39.45%	(130.41%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-106.76,"profit":false},{"date":"2022-12-31","value":-321.66,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-330.55,"profit":false}]

Total Liabilities & Shareholders Equity	-	6.93%	(2.66%)	7.99%	10.71%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":64.75,"profit":true},{"date":"2022-12-31","value":-24.85,"profit":false},{"date":"2023-12-31","value":74.66,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	3.36B	3.30B	3.27B	3.64B	3.95B	[{"date":"2024-09-30","value":84.89,"profit":true},{"date":"2024-12-31","value":83.37,"profit":true},{"date":"2025-03-31","value":82.68,"profit":true},{"date":"2025-06-30","value":92.18,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	849.62M	944.70M	945.55M	922.32M	898.85M	[{"date":"2024-09-30","value":89.85,"profit":true},{"date":"2024-12-31","value":99.91,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":97.54,"profit":true},{"date":"2025-09-30","value":95.06,"profit":true}]
Total Assets	4.21B	4.24B	4.21B	4.57B	4.85B	[{"date":"2024-09-30","value":86.67,"profit":true},{"date":"2024-12-31","value":87.39,"profit":true},{"date":"2025-03-31","value":86.85,"profit":true},{"date":"2025-06-30","value":94.11,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	1.22B	1.19B	1.08B	1.30B	1.56B	[{"date":"2024-09-30","value":78.48,"profit":true},{"date":"2024-12-31","value":76.26,"profit":true},{"date":"2025-03-31","value":69.15,"profit":true},{"date":"2025-06-30","value":83.63,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	2.95B	2.99B	3.02B	3.01B	3.06B	[{"date":"2024-09-30","value":96.4,"profit":true},{"date":"2024-12-31","value":97.53,"profit":true},{"date":"2025-03-31","value":98.71,"profit":true},{"date":"2025-06-30","value":98.44,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	4.17B	4.17B	4.10B	4.32B	4.62B	[{"date":"2024-09-30","value":90.36,"profit":true},{"date":"2024-12-31","value":90.37,"profit":true},{"date":"2025-03-31","value":88.75,"profit":true},{"date":"2025-06-30","value":93.45,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	1.29M	1.29M	1.30M	1.31M	1.32M	[{"date":"2024-09-30","value":97.8,"profit":true},{"date":"2024-12-31","value":98.1,"profit":true},{"date":"2025-03-31","value":98.86,"profit":true},{"date":"2025-06-30","value":99.39,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(7.20B)	(7.29B)	(7.35B)	(7.41B)	(7.16B)	[{"date":"2024-09-30","value":-720398500000,"profit":false},{"date":"2024-12-31","value":-728774800000,"profit":false},{"date":"2025-03-31","value":-734522700000,"profit":false},{"date":"2025-06-30","value":-741150400000,"profit":false},{"date":"2025-09-30","value":-716042000000,"profit":false}]
Other Stockholders' Equity	7.26B	7.39B	7.50B	7.69B	7.41B	[{"date":"2024-09-30","value":94.4,"profit":true},{"date":"2024-12-31","value":96.06,"profit":true},{"date":"2025-03-31","value":97.48,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":96.41,"profit":true}]
Total Shareholders' equity	32.35M	67.09M	115.44M	250.59M	233.89M	[{"date":"2024-09-30","value":12.91,"profit":true},{"date":"2024-12-31","value":26.77,"profit":true},{"date":"2025-03-31","value":46.07,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":93.34,"profit":true}]

Total Liabilities & Shareholders Equity	4.21B	4.24B	4.21B	4.57B	4.85B	[{"date":"2024-09-30","value":86.67,"profit":true},{"date":"2024-12-31","value":87.39,"profit":true},{"date":"2025-03-31","value":86.85,"profit":true},{"date":"2025-06-30","value":94.11,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(1.79%)	(0.82%)	11.49%	8.48%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-15.6,"profit":false},{"date":"2025-03-31","value":-7.14,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":73.85,"profit":true}]
Non-current Assets	-	11.19%	0.09%	(2.46%)	(2.54%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":0.81,"profit":true},{"date":"2025-06-30","value":-21.96,"profit":false},{"date":"2025-09-30","value":-22.74,"profit":false}]
Total Assets	-	0.83%	(0.62%)	8.36%	6.26%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":9.94,"profit":true},{"date":"2025-03-31","value":-7.38,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":74.84,"profit":true}]

Total Liabilities
Current Liabilities	-	(2.82%)	(9.33%)	20.94%	19.57%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-13.46,"profit":false},{"date":"2025-03-31","value":-44.55,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":93.48,"profit":true}]
Non-current Liabilities	-	1.17%	1.21%	(0.27%)	1.58%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":74.06,"profit":true},{"date":"2025-03-31","value":76.44,"profit":true},{"date":"2025-06-30","value":-17.08,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	-	0.01%	(1.79%)	5.30%	7.01%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.07,"profit":true},{"date":"2025-03-31","value":-25.49,"profit":false},{"date":"2025-06-30","value":75.59,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	0.31%	0.77%	0.54%	0.61%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":40.12,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":69.46,"profit":true},{"date":"2025-09-30","value":78.96,"profit":true}]
Retained Earnings	-	1.16%	0.79%	0.90%	(3.39%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":67.83,"profit":true},{"date":"2025-06-30","value":77.6,"profit":true},{"date":"2025-09-30","value":-291.36,"profit":false}]
Other Stockholders' Equity	-	1.77%	1.47%	2.59%	(3.59%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":68.28,"profit":true},{"date":"2025-03-31","value":56.96,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-138.76,"profit":false}]
Total Shareholders' equity	-	107.36%	72.07%	117.08%	(6.66%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":91.69,"profit":true},{"date":"2025-03-31","value":61.55,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-5.69,"profit":false}]

Total Liabilities & Shareholders Equity	-	0.83%	(0.62%)	8.36%	6.26%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":9.94,"profit":true},{"date":"2025-03-31","value":-7.38,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":74.84,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(614.96M)	(641.69M)	(541.27M)	104.16M	(8.31M)	[{"date":"2020-12-31","value":-590.42,"profit":false},{"date":"2021-12-31","value":-616.09,"profit":false},{"date":"2022-12-31","value":-519.68,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-7.98,"profit":false}]

Investing Activities
Net Investing Cash Flow	(435.52M)	(273.30M)	169.35M	(336.35M)	(116.84M)	[{"date":"2020-12-31","value":-257.16,"profit":false},{"date":"2021-12-31","value":-161.38,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-198.61,"profit":false},{"date":"2024-12-31","value":-68.99,"profit":false}]

Financing Activities
Net Financing Cash Flow	994.98M	1.25B	425.75M	172.13M	294.16M	[{"date":"2020-12-31","value":79.78,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":34.14,"profit":true},{"date":"2023-12-31","value":13.8,"profit":true},{"date":"2024-12-31","value":23.59,"profit":true}]

Net Change in Cash	(50.58M)	323.11M	46.40M	(53.67M)	153.77M	[{"date":"2020-12-31","value":-15.65,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":14.36,"profit":true},{"date":"2023-12-31","value":-16.61,"profit":false},{"date":"2024-12-31","value":47.59,"profit":true}]

Free Cash Flow
Free Cash Flow	(685.32M)	(718.07M)	(613.33M)	41.95M	(42.59M)	[{"date":"2020-12-31","value":-1633.86,"profit":false},{"date":"2021-12-31","value":-1711.92,"profit":false},{"date":"2022-12-31","value":-1462.23,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-101.54,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	4.35%	(15.65%)	(119.24%)	(107.98%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-360,"profit":false},{"date":"2023-12-31","value":-2743.14,"profit":false},{"date":"2024-12-31","value":-2484.05,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(37.25%)	(161.97%)	(298.61%)	(65.26%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	25.34%	(65.86%)	(59.57%)	70.89%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":35.75,"profit":true},{"date":"2022-12-31","value":-92.9,"profit":false},{"date":"2023-12-31","value":-84.03,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	(738.78%)	(85.64%)	(215.66%)	(386.50%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	4.78%	(14.59%)	(106.84%)	(201.54%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-305.28,"profit":false},{"date":"2023-12-31","value":-2236.17,"profit":false},{"date":"2024-12-31","value":-4218.2,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	43.71M	(94.66M)	(118.31M)	153.73M	325.11M	[{"date":"2024-09-30","value":13.44,"profit":true},{"date":"2024-12-31","value":-29.12,"profit":false},{"date":"2025-03-31","value":-36.39,"profit":false},{"date":"2025-06-30","value":47.29,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	(30.25M)	(52.91M)	113.77M	(141.38M)	501.11M	[{"date":"2024-09-30","value":-6.04,"profit":false},{"date":"2024-12-31","value":-10.56,"profit":false},{"date":"2025-03-31","value":22.7,"profit":true},{"date":"2025-06-30","value":-28.21,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	102.75M	31.00M	44.08M	53.76M	(448.35M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":30.17,"profit":true},{"date":"2025-03-31","value":42.9,"profit":true},{"date":"2025-06-30","value":52.32,"profit":true},{"date":"2025-09-30","value":-436.33,"profit":false}]

Net Change in Cash	131.31M	(133.85M)	53.60M	93.61M	376.94M	[{"date":"2024-09-30","value":34.83,"profit":true},{"date":"2024-12-31","value":-35.51,"profit":false},{"date":"2025-03-31","value":14.22,"profit":true},{"date":"2025-06-30","value":24.83,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	39.52M	(103.76M)	(127.28M)	139.44M	312.97M	[{"date":"2024-09-30","value":12.63,"profit":true},{"date":"2024-12-31","value":-33.15,"profit":false},{"date":"2025-03-31","value":-40.67,"profit":false},{"date":"2025-06-30","value":44.55,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(316.58%)	24.99%	(229.93%)	111.48%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-283.98,"profit":false},{"date":"2025-03-31","value":22.41,"profit":true},{"date":"2025-06-30","value":-206.25,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	74.91%	(315.02%)	(224.27%)	(454.44%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-420.54,"profit":false},{"date":"2025-06-30","value":-299.39,"profit":false},{"date":"2025-09-30","value":-606.65,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(69.83%)	42.22%	21.94%	(934.03%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-165.4,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":51.97,"profit":true},{"date":"2025-09-30","value":-2212.27,"profit":false}]

Net Change in Cash	-	(201.94%)	(140.04%)	74.66%	302.66%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-66.72,"profit":false},{"date":"2025-03-31","value":-46.27,"profit":false},{"date":"2025-06-30","value":24.67,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(362.57%)	22.68%	(209.55%)	124.45%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-291.34,"profit":false},{"date":"2025-03-31","value":18.22,"profit":true},{"date":"2025-06-30","value":-168.38,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Alnylam Pharmaceuticals Inc Ratios

Alnylam Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	ALNY
Cash Ratio	1.75
Current Ratio	2.54
Quick Ratio	2.49

Alnylam Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	ALNY
ROA (LTM)	3.65%
ROE (LTM)	32.72%

Alnylam Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	ALNY
Debt Ratio Lower is generally better. Negative is bad.	0.95
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.05

Alnylam Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	ALNY
Trailing PE	1093.87
Forward PE	45.05
P/S (TTM)	13.51
P/B	185.36
Price/FCF	139
EV/R	13.06
EV/Ebitda	224.70
PEG	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Alnylam Pharmaceuticals Inc share price today?

Alnylam Pharmaceuticals Inc (ALNY) share price today is $320

Can Indians buy Alnylam Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Alnylam Pharmaceuticals Inc (ALNY) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ALNY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Alnylam Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Alnylam Pharmaceuticals Inc (ALNY) via the Vested app. You can start investing in Alnylam Pharmaceuticals Inc (ALNY) with a minimum investment of $1.

How to invest in Alnylam Pharmaceuticals Inc shares from India?

You can invest in shares of Alnylam Pharmaceuticals Inc (ALNY) via Vested in three simple steps:

Click on Sign Up or Invest in ALNY stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Alnylam Pharmaceuticals Inc shares

What is Alnylam Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Alnylam Pharmaceuticals Inc (ALNY) is $495.55. The 52-week low price of Alnylam Pharmaceuticals Inc (ALNY) is $205.87.

What is Alnylam Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Alnylam Pharmaceuticals Inc (ALNY) is 1093.8666

What is Alnylam Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Alnylam Pharmaceuticals Inc (ALNY) is 185.36

What is Alnylam Pharmaceuticals Inc dividend yield?

The dividend yield of Alnylam Pharmaceuticals Inc (ALNY) is 0.00%

What is the Market Cap of Alnylam Pharmaceuticals Inc?

The market capitalization of Alnylam Pharmaceuticals Inc (ALNY) is $43.35B

What is Alnylam Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Alnylam Pharmaceuticals Inc is ALNY

How Can Investors Use Alnylam Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Alnylam Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Alnylam Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Alnylam Pharmaceuticals Inc shares for Indian investors?

When investing in Alnylam Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Alnylam Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Alnylam Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Alnylam Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Alnylam Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Alnylam Pharmaceuticals Inc Share Price

Alnylam Pharmaceuticals Inc Analyst Forecast

Alnylam Pharmaceuticals Inc Share Price Chart

Alnylam Pharmaceuticals Inc Key Stock Metrics

About Alnylam Pharmaceuticals Inc, Common Stock

Alnylam Pharmaceuticals Inc Stock Returns

Alnylam Pharmaceuticals Inc Financials

Alnylam Pharmaceuticals Inc Ratios

Alnylam Pharmaceuticals Inc Liquidity Ratios

Alnylam Pharmaceuticals Inc Asset Efficiency Ratios

Alnylam Pharmaceuticals Inc Liability Ratios

Alnylam Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Alnylam Pharmaceuticals Inc Share Price

Alnylam Pharmaceuticals Inc Analyst Forecast

Alnylam Pharmaceuticals Inc Share Price Chart

Alnylam Pharmaceuticals Inc Key Stock Metrics

About Alnylam Pharmaceuticals Inc, Common Stock

Alnylam Pharmaceuticals Inc Stock Returns

Alnylam Pharmaceuticals Inc Financials

Alnylam Pharmaceuticals Inc Ratios

Alnylam Pharmaceuticals Inc Liquidity Ratios

Alnylam Pharmaceuticals Inc Asset Efficiency Ratios

Alnylam Pharmaceuticals Inc Liability Ratios

Alnylam Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²